Interest in NKX2.2 at AACR 2025

Hello Scientist,

Another busy AACR is in the books! We followed several interesting topics this year, but notably NKX2.2 was one of the most frequently studied targets of interest.

Benchmark Antibodies has now expanded the premium IVD for R&D reagent catalogue to include diagnostic grade NKX2.2 antibody clones:

IVD for R&D precision antibodies are developed by pathologists to provide diagnostic grade target specificity and reproducibility validated reagents for your IHC research applications.

Why use IVD reagents for research applications? The IVD for R&D clones are invaluable for eliminating the guess-work and inconsistencies of research grade reagents.

RELIABLE QUALITY – ISO/GMP monoclonal manufacturing and IVD validation guarantees batch consistency and reproducibility ECONOMICAL – IVD workflow reagents ensure uninterrupted supply and lowest market prices EASY-TO-USE – Well characterized protocols with real-time North American technical support and order fulfillment	Human Ewing’ss sarcoma. Human Ewing’ss sarcoma stained with anti-NKX2.2 antibody using peroxidase-conjugate and DAB chromogen. Note nuclear staining of tumor cells. TECHNICAL RESOURCES: Immunohistochemistry Protocol Anti-NKX2.2 rabbit monoclonal antibody (ZR438) 6290

Please visit us and feel free to contact us if you have any questions or if we can provide you with additional information.
We look forward to hearing from you!

Best regards,
Team Benchmark